EichorEICHOR
Location: Cincinnati Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Cincinnati

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · University of Cincinnati Medical Center · Eli Lilly and Company · NCT07218380
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University of Cincinnati Medical Center · Joseph Broderick, MD · NCT07227246
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · University Of Cincinnati · Novartis Pharmaceuticals · NCT05755386
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · TriState Urologic Services PSC Inc. dba The Urology Group · Pfizer · NCT07028853
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · University of Cincinnati Physicians Group, LLC · Daiichi Sankyo · NCT07022483
Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery
NA · Cincinnati Children's Hospital Medical Center · Children's Hospital Medical Center, Cincinnati · NCT05622461
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Cincinnati Children's Hospital Medical Center · Arkansas Children's Hospital Research Institute · NCT03827694
Suicide Treatment Alternatives for Teens
NA · Cincinnati Children's Hospital and Medical Center · Children's Hospital Medical Center, Cincinnati · NCT04089254
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 2401, Cincinnati CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · The Christ Hospital · Edwards Lifesciences · NCT05172973
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2 · Cincinnati Children's Hospital Medical Center · Darcy Krueger · NCT05104983
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Cincinnati Children's Hospital Medical Center · National Cancer Institute (NCI) · NCT05099003
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · Oncology/Hematology Care, Inc. · BioNTech SE · NCT07365995
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · University of Cincinnati Medical Center · Bristol-Myers Squibb · NCT06929273
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Cincinnati Children's Hospital Medical Center · National Cancer Institute (NCI) · NCT06172296
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Cincinnati Cancer Center-UC Medical Center · NRG Oncology · NCT05624996
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Cincinnati Children's Hospital Medical Center - PIN · H. Lundbeck A/S · NCT05897320
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Phase 2 · Christ Hospital · XyloCor Therapeutics, Inc. · NCT07048808
Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study
Phase N/A · Cincinnati Children's Hospital Medical Center · Children's Hospital Medical Center, Cincinnati · NCT07636525
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Cincinnati Children's Hospital Medical Center · Relay Therapeutics, Inc. · NCT06789913
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
Phase N/A · Cincinnati Children's Hospital Medical Center · Children's Hospital Medical Center, Cincinnati · NCT05556642
Overlapping Pain Trajectory Study
Phase N/A · Cincinnati Children's Hospital · Children's Hospital Medical Center, Cincinnati · NCT05752396
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · University of Cincinnati Medical Center · University of Cincinnati · NCT05911568
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Phase N/A · University of Cincinnati · Tempus AI · NCT07154823
BiVACOR® Total Artificial Heart Early Feasibility Study
NA · The Christ Hospital · BiVACOR Inc. · NCT06174103
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Phase 1 · Medpace Clinical Pharmacology Unit · Hanmi Pharmaceutical Company Limited · NCT07219589
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · University of Cincinnati Cancer Institute · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404
A Study of Uveitis in Children <18 Years of Age
Phase N/A · Cincinnati Children's Hospital Medical Center · Jaeb Center for Health Research · NCT07518134
Registry for Stage 2 Type 1 Diabetes
Phase N/A · Cincinnati Children's Hospital Medical Center- Site Number : · Sanofi · NCT06481904
Look up another city
Look up another condition